DE69919171D1 - Muskarin-rezeptor antagonisten - Google Patents
Muskarin-rezeptor antagonistenInfo
- Publication number
- DE69919171D1 DE69919171D1 DE69919171T DE69919171T DE69919171D1 DE 69919171 D1 DE69919171 D1 DE 69919171D1 DE 69919171 T DE69919171 T DE 69919171T DE 69919171 T DE69919171 T DE 69919171T DE 69919171 D1 DE69919171 D1 DE 69919171D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor antagonists
- muscarine receptor
- muscarine
- antagonists
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10798398A | 1998-06-30 | 1998-06-30 | |
| US107983 | 1998-06-30 | ||
| PCT/US1999/012821 WO2000000488A1 (en) | 1998-06-30 | 1999-06-28 | Muscarinic antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69919171D1 true DE69919171D1 (de) | 2004-09-09 |
| DE69919171T2 DE69919171T2 (de) | 2005-08-04 |
Family
ID=22319562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69919171T Expired - Lifetime DE69919171T2 (de) | 1998-06-30 | 1999-06-28 | Muskarin-rezeptor antagonisten |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1091956B1 (de) |
| JP (1) | JP3344997B2 (de) |
| KR (1) | KR20010053254A (de) |
| CN (1) | CN1146559C (de) |
| AR (1) | AR019167A1 (de) |
| AT (1) | ATE272632T1 (de) |
| AU (1) | AU756484B2 (de) |
| CA (1) | CA2336000C (de) |
| DE (1) | DE69919171T2 (de) |
| ES (1) | ES2221399T3 (de) |
| HU (1) | HUP0104058A2 (de) |
| IL (1) | IL140249A0 (de) |
| MY (1) | MY133108A (de) |
| NZ (1) | NZ508910A (de) |
| TW (1) | TW474933B (de) |
| WO (1) | WO2000000488A1 (de) |
| ZA (1) | ZA200007555B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6635646B1 (en) | 1999-05-04 | 2003-10-21 | Schering Corporation | Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| US6689765B2 (en) | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| US6391865B1 (en) | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
| RU2299206C9 (ru) * | 1999-05-04 | 2007-11-20 | Шеринг Корпорейшн | Производные пиперазина, фармацевтические композиции, их содержащие, и применение в качестве антагонистов ccr5 |
| ES2215055T3 (es) * | 1999-09-22 | 2004-10-01 | Schering Corporation | Antagonistas muscarinicos. |
| US6294554B1 (en) | 1999-09-22 | 2001-09-25 | Schering Corporation | Muscarinic antagonists |
| AR033517A1 (es) | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| AU2002244271A1 (en) * | 2001-03-13 | 2002-09-24 | Pharmacopeia, Inc. | Non-imidazole compounds as histamine h3 antagonists |
| EP1604982A1 (de) | 2001-07-02 | 2005-12-14 | AstraZeneca AB | Zwischenverbindungen für die herstellung von piperidinverbindungen, die sich als modulatoren der chemokinrezeptoraktivität eignen |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200843D0 (sv) | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| EP1888527A1 (de) * | 2005-05-27 | 2008-02-20 | AstraZeneca AB | Piperidine zur behandlung von chemokinvermittelten krankheiten |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| MX2008000821A (es) | 2005-07-21 | 2008-03-19 | Astrazeneca Ab | Nuevos derivados de piperidina. |
| CA2681162C (en) | 2007-03-15 | 2015-11-24 | Novartis Ag | Benzyl and pyridine derivatives as modulators of hedgehog pathway |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| CN104356056B (zh) * | 2014-11-19 | 2017-04-05 | 南京华威医药科技开发有限公司 | 吡仑帕奈中间体的制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
-
1999
- 1999-06-28 AU AU48201/99A patent/AU756484B2/en not_active Ceased
- 1999-06-28 KR KR1020007014935A patent/KR20010053254A/ko not_active Application Discontinuation
- 1999-06-28 AR ARP990103104A patent/AR019167A1/es unknown
- 1999-06-28 AT AT99931768T patent/ATE272632T1/de not_active IP Right Cessation
- 1999-06-28 EP EP99931768A patent/EP1091956B1/de not_active Expired - Lifetime
- 1999-06-28 JP JP2000557249A patent/JP3344997B2/ja not_active Expired - Fee Related
- 1999-06-28 WO PCT/US1999/012821 patent/WO2000000488A1/en active IP Right Grant
- 1999-06-28 CA CA002336000A patent/CA2336000C/en not_active Expired - Fee Related
- 1999-06-28 MY MYPI99002663A patent/MY133108A/en unknown
- 1999-06-28 CN CNB998100765A patent/CN1146559C/zh not_active Expired - Fee Related
- 1999-06-28 TW TW088110871A patent/TW474933B/zh not_active IP Right Cessation
- 1999-06-28 IL IL14024999A patent/IL140249A0/xx unknown
- 1999-06-28 HU HU0104058A patent/HUP0104058A2/hu unknown
- 1999-06-28 ES ES99931768T patent/ES2221399T3/es not_active Expired - Lifetime
- 1999-06-28 DE DE69919171T patent/DE69919171T2/de not_active Expired - Lifetime
- 1999-06-28 NZ NZ508910A patent/NZ508910A/xx unknown
-
2000
- 2000-12-15 ZA ZA200007555A patent/ZA200007555B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ508910A (en) | 2003-01-31 |
| WO2000000488A1 (en) | 2000-01-06 |
| DE69919171T2 (de) | 2005-08-04 |
| EP1091956A1 (de) | 2001-04-18 |
| TW474933B (en) | 2002-02-01 |
| CA2336000A1 (en) | 2000-01-06 |
| HUP0104058A2 (hu) | 2002-03-28 |
| CN1314905A (zh) | 2001-09-26 |
| CA2336000C (en) | 2006-10-10 |
| AU756484B2 (en) | 2003-01-16 |
| CN1146559C (zh) | 2004-04-21 |
| AU4820199A (en) | 2000-01-17 |
| AR019167A1 (es) | 2001-12-26 |
| ZA200007555B (en) | 2002-03-15 |
| IL140249A0 (en) | 2002-02-10 |
| MY133108A (en) | 2007-10-31 |
| EP1091956B1 (de) | 2004-08-04 |
| JP2002519349A (ja) | 2002-07-02 |
| ATE272632T1 (de) | 2004-08-15 |
| KR20010053254A (ko) | 2001-06-25 |
| ES2221399T3 (es) | 2004-12-16 |
| JP3344997B2 (ja) | 2002-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012411D0 (no) | Pyrrolidin-derivater-CCR-3-reseptorantagonister | |
| ATE280157T1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| ATE233260T1 (de) | Muscarin-antagonisten | |
| NO20001100D0 (no) | IL-8 reseptorantagonister | |
| IS5706A (is) | Adenosín A3 viðtakastillar | |
| DE69905248T2 (de) | Neuropeptid y5-rezeptorantagonisten | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| ATE272632T1 (de) | Muskarin-rezeptor antagonisten | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| NO20016053D0 (no) | IL-8 reseptor-antagonister | |
| ID26086A (id) | Ligan-ligan reseptor 5ht1 azabisiklik | |
| DE69838874D1 (de) | Il-8 rezeptor-antagonisten | |
| NO20016052D0 (no) | IL-8-reseptor-antagonister | |
| ID28811A (id) | Antagonis reseptor vitronektin | |
| ATE303370T1 (de) | Il-8 rezeptor antagonisten | |
| DK1180028T3 (da) | IL-8-receptorantagonister | |
| ATE264301T1 (de) | Muscarin-antagonisten | |
| DE69824837D1 (de) | Il-8-rezeptor-antagonisten | |
| NO20015774L (no) | IL-8 reseptorantagonister | |
| NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
| NO20010353L (no) | IL-8 reseptor-antagonist | |
| NO20016102D0 (no) | IL-8 reseptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |